Perspectives on the Future of Pharmaceuticals Lunch Discussion Series

The purpose of the "Perspectives" Lunch Series is to create a forum for thoughtful roundtable discussion stimulated by brief presentations given by speakers from academia, industry, and government followed by extended discussion. Each presentation emphasizes the future needs and hurdles of drug design, development and delivery.

2013

John McDonald
Georgia Institute of Technology
Development and delivery of small RNAs for cancer therapy
April 22, 2013

Paloma Giangrande
Universiy of Iowa
Targeted intracellular delivery and endosomal escape
April 2, 2013

Constantin Coussios
University of Oxford
Devices are the future for drug delivery and drug targeting
March 6, 2013

 

2012

Craig Townsend
Johns Hopkins University
Can we apply synthetic biology to make carbapenem  beta-lactam antiobiotics more cheaply?
November 1, 2012

Matthew Shair
Harvard University
Using small molecules to identify novel therapeutics targets
October 11, 2012

David Mooney
Harvard University
In vivo gene therapy with plasmid DNA
September 12, 2012

Rami Hannoush
Genentech
Drug Discovery Approaches for Lead Chemical Matter
March 28, 2012

Georges Belfort
Renneslaer Polytechnic Institute
Biocompatible Surfaces:  Where Do We Go Now?
February 15, 2012

Binghe Wang
Georgia State University
Drug Discovery and Medicinal Chemistry
February 2, 2012

 

2011

David Putnam
Cornell University
Challenges in Formulation and Delivery: Polymorphs and Proteins
November 3, 2011

Jason Gestwicki
University of Michigan
Biotechnology Start-up Companies
October 13, 2011

VictoriaLunyak
Buck Institute for Research on Aging
Epigenetics, Stem Cells, and Aging
September 15, 2011

James Swartz
Stanford University
Virus-Like Nanoparticles as Drug Delivery Vehicles
April 20, 2011

David C. Klonoff, M.D.
University of California, San Francisco
Novel Technologies for Insulin Delivery for Patients with Diabetes
April 6, 2011

Dennis Liotta
Department of Chemistry, Emory University
Drug Design in Cancer and Inflammation
February 2, 2011

2010

Marvin Whiteley, PhD
The University of Texas at Austin
Therapeutics Targeting Microbial Communications Pathways
December 16, 2010

Christine Dunham
Emory University School of Medicine
Future of Antibiotics
October 26, 2010

Ben Shen
University of Wisconsin, Madison
Natural Product Drug Discovery and Development
April 5, 2010

Justin Hanes
Johns Hopkins University
Nanoparticle Pharmaceuticals
March 3, 1010

2009

David Schaffer
University of California, Berkeley
Stem Cell Delivery
December 2, 2009

William L. Murphy
University of Wisconsin
Bioresponsive Drug Delivery
October 29, 2009

Barbara Gerratana
University of Maryland, College Park
New Hopes in the Fight Against TB
May 7, 2009

David Wilson
Georgia State University
The Future of Nucleic Acid-Targeting Therapeutic Agents
April 14, 2009

Jeff Hubbell
Ecole Polytechnique Fédérale de Lausanne
The Future of Immunotherapeutics
February 3, 2009

2008

Eric Tomlinson
Altea Therapeutics
Delivering Biotherapeutics Better – Why it Matters
November 3, 2008

Eric Felner
Division of Pediatric Endocrinology, Emory University School of Medicine
New Drugs and Delivery Systems in Diabetes and Endocrinology
May 19, 2008

Daniel Pack
University of Illinois
Gene Delivery
March 12, 2008

2007

Anne Skaja Robinson,
Department of Chemical Engineering, University of Delaware
Designing Proteins and Cells for Drug Screening
November 14, 2007

Wei-Shou Hu,
Department of Chemical Engineering and Materials Science, University of Minnesota
Metabolic Engineering for Protein Production
October 25, 2007

J. Brad Chaires,
James Grahem Brown Cancer Center, University of Louisville
Targeting Nucleic Acids
September 13, 2007

Kristi Anseth,
Howard Hughes Medical Center, University of Colorado at Boulder
Pharmaceutical Biomaterials
August 29, 2007

Robert Prud'homme,
Professor of Chemical Engineering, Princeton University
Nanoparticle Pharmaceuticals
April 18, 2007

Stanley Foster, MD, MPH,
Professor of Global Health, Emory University
Medical Therapies in Africa: The past, present, and future of measles in African children
March 29, 2007

Sidney Hecht, Chemistry,
University of Virginia
Discovery of Drugs that Target Mitochondrial Respiration
March 1, 2007

2006

Michael T. Bowser,
Department of Chemistry, University of Minnesota
The Future of Aptamers in Pharmaceutical Research
November 2, 2006

Antonios Mikos,
Department of Bioengineering, Rice University
Drug Delivery Systems for Tissue Engineering Applications
October 5, 2006

Samir Mitragotri,
Department of Chemical Engineering, University of California, Santa Barbara
High Throughput Screening Methods in Drug Delivery Applications
September 13, 2006

William Roush,
Kellogg School of Science and Technology, The Scripps Research Institute, Florida
Strategies to Address the 9% Problem
April 20, 2006

Jennifer Fiegal,
Division of Engineering and Applied Sciences, Harvard University
Barriers to Developing-World Health
February 15, 2006

2005

William Gerwick,
College of Pharmacy, Oregon State University
The Future of Pharmacy from the Sea
November 30, 2005

Jonathan Dordick,
Department of Chemical Engineering, Rensselaer Polytechnic Institute
Major Bottlenecks in the Pharmaceutical Industry
November 16, 2005

Dennis Liotta,
Department of Chemistry, Emory University
The Future of High-throughput Drug Discovery
October 25, 2005

Ajay Banga,
Chairman and Professor, Department of Pharmaceutical Sciences,
Mercer University Southern School of Pharmacy
The Future of Pharmaceutical Education
April 26, 2005

John Katzenellenbogen,
Swanlund Professor of Chemistry, University of Illinois at Urbana-Champaign
Steroid Hormones and Drug Design
February 17, 2005

Alan Minsk, Esq
Food and Drug Practice Team, Arnall Golden Gregory LLP
Nanotechnology, Nanomedicine, and Regulations
January 27, 2005

2004

Joseph LeDoux, PhD
Department of Biomedical Engineering, Georgia Tech/Emory
Gene Therapy
December 2, 2004

Janet Tamada,
Senior Director, Product and Process Development, Alexza MDC
Cost-Effective Drug Delivery for Unmet Needs
September 22, 2004

Mark Prausnitz, PhD
School of Chemical and Biomolecular Engineering, Georgia Tech
The Need for New Routes and Carriers for Drug Delivery
May 26, 2004

Sheldon May,
School of Chemistry and Biochemistry, Georgia Tech
Lessons and Perspectives from Two Excursions in Drug Design and Development
March 31, 2004

Andy Bommarius, PhD
School of Chemical and Biomolecular Engineering, Georgia Tech
Drug Screening and Processing
February 20, 2004